December 1, 2016 - By Louis Casey · 0 Comments
Hill-rom Holdings Inc (NYSE:HRC) institutional sentiment increased to 1.38 in Q2 2016. Its up 0.09, from 1.29 in 2016Q1. The ratio increased, as 126 investment professionals increased or started new positions, while 98 reduced and sold stock positions in Hill-rom Holdings Inc. The investment professionals in our partner’s database now hold: 53.93 million shares, down from 54.02 million shares in 2016Q1. Also, the number of investment professionals holding Hill-rom Holdings Inc in their top 10 positions decreased from 2 to 0 for a decrease of 2. Sold All: 19 Reduced: 79 Increased: 91 New Position: 35.
Hill-Rom Holdings, Inc. is a global medical technology company. The company has a market cap of $3.43 billion. The Firm operates through four divisions: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. It has a 28.45 P/E ratio. The Company’s services and products include Patient Support Systems, Front Line Care and Surgical Solutions.
About 100,813 shares traded hands. Hill-Rom Holdings, Inc. (NYSE:HRC) has risen 0.45% since April 28, 2016 and is uptrending. It has underperformed by 5.47% the S&P500.
Analysts await Hill-Rom Holdings, Inc. (NYSE:HRC) to report earnings on February, 6. They expect $0.77 EPS, up 13.24% or $0.09 from last year’s $0.68 per share. HRC’s profit will be $49.95 million for 17.17 P/E if the $0.77 EPS becomes a reality. After $1.18 actual EPS reported by Hill-Rom Holdings, Inc. for the previous quarter, Wall Street now forecasts -34.75% negative EPS growth.
According to Zacks Investment Research, “HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.”
Nine Chapters Capital Management Llc holds 4.43% of its portfolio in Hill-Rom Holdings, Inc. for 4,200 shares. Sterling Investment Management Inc. owns 14,700 shares or 3.06% of their US portfolio. Moreover, Bernzott Capital Advisors has 2.65% invested in the company for 269,536 shares. The Massachusetts-based Copper Rock Capital Partners Llc has invested 2.25% in the stock. Healthcor Management L.P., a New York-based fund reported 815,603 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 0 buys, and 1 insider sale for $2.22 million net activity.
Ratings analysis reveals 75% of Hill-Rom’s analysts are positive. Out of 4 Wall Street analysts rating Hill-Rom, 3 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $61 while the high is $62. The stock’s average target of $61.50 is 16.32% above today’s ($52.87) share price. HRC was included in 4 notes of analysts from September 23, 2015. On Wednesday, December 16 the stock rating was upgraded by Northcoast to “Buy”. The stock of Hill-Rom Holdings, Inc. (NYSE:HRC) earned “Overweight” rating by KeyBanc Capital Markets on Thursday, January 21. The firm has “Overweight” rating given on Thursday, June 16 by Morgan Stanley. As per Wednesday, September 23, the company rating was reinitiated by Goldman Sachs.
Hill-Rom Holdings, Inc., incorporated on August 7, 1969, is a medical technology company. The Firm offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. The Company’s divisions include North America, Surgical and Respiratory Care, International and Welch Allyn. The North America segment sells and rents its support and near-patient technologies and services, as well as clinical workflow solutions in the United States and Canada. The Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products across the globe. The International segment sells and rents similar products as the Company’s North America segment in regions outside of the United States and Canada. The Welch Allyn segment sells medical diagnostic equipment and a portfolio of devices that assess, diagnose, treat and manage a range of illnesses and diseases across the globe.
More news for Hill-Rom Holdings, Inc. (NYSE:HRC) were recently published by: Prnewswire.com, which released: “Hill-Rom Holdings, Inc., to Host Fiscal Fourth Quarter 2016 Earnings …” on September 29, 2016. Prnewswire.com‘s article titled: “Hill-Rom Declares First Quarter 2017 Dividend” and published on November 16, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Louis Casey